Aging
Our work in Aging
-
Barriers to Seeking Care for Memory Problems: A Vignette Study
Abstract Introduction: This study compares how older adults judge the need for follow-up care for memory-related problems when they are responding about themselves versus someone of the same age. Methods: Adults ages 65 and over in the Understanding America Study, a nationally representative internet panel, were invited to participate in a short survey with three […]
Categorized in Research -
The Rising Burden of Alzheimer’s Disease Mortality in Rural America
Since the 1990s, there has been a striking urban-rural divergence in life expectancy within the United States, with metropolitan areas achieving strong life expectancy increases and nonmetropolitan areas experiencing stagnation or actual declines in life expectancy.
-
Global Projections of Dementia: United States, Ireland, Japan and Mexico
On March 9, join a webinar on projections of population-level cognitive impairment and dementia in the US, Ireland, Japan, and Mexico. The panel will also discuss how simulation modeling can be used for projecting costs and health outcomes of new therapeutics for AD/ADRD.
-
New USC Study Finds People of Color Live More Years with Dementia Diagnosis Than Non-Hispanic Whites
These findings further reinforce the need for targeted support and resources for families and patients living with Alzheimer’s and other dementias.
-
Aduhelm Decision Shows Medicare is Making a Mistake in the Fight Against Alzheimer’s
The medical need is too great that the FDA should not limit targeted therapies and diagnostics.
Categorized in Evidence Base -
Improving Care of People with Serious Medical Illness: An Economic Research Agenda for Palliative Care
In 2020, Schaeffer Center established an Advisory Panel on Palliative Care. In this post, the panel outlines next steps to increase the quality of care of frail people with multiple chronic conditions.
Categorized in Evidence Base -
Substance Use Disorders Among Older Populations: What Role Do Race and Ethnicity Play in Treatment and Completion?
Researchers provide historical investigation of admissions and discharges for treatment episodes over the past two decades across race, ethnicity, gender, and age.
-
Pilot Funding Available for Researchers of Alzheimer’s, Aging
Pilot funding amounts range from $25,000 to up to $45,000. An informational session on the application process will be held over zoom on Thursday, December 9, 2021, at 10:00 a.m. pacific.
-
The Costs of Developing Treatments for Alzheimer’s Disease: A Retrospective Exploration
In over 26 years of research and development in Alzheimer’s disease, only six novel drugs have reached FDA approval.
-
NAM Expert Briefing on Social Science Research Questions Raised By the Use of Biomarkers for Alzheimer’s Disease Diagnostics
On June 28 and 29, 2021, the National Academies of Sciences, Engineering, and Medicine convened an expert meeting that addressed behavioral and social science research questions raised by the use of biomarkers and other measures for pre-clinical AD/ADRD diagnosis